Global Haemostats Market (Flowables, Thrombin & Fibrin Sealants): Industry Analysis & Outlook (2019-2023)

Global Haemostats Market (Flowables, Thrombin & Fibrin Sealants): Industry Analysis & Outlook (2019-2023)

Haemostat is a type of haemostatic instrument, which is designed to be used during the vascular surgeries to control bleeding, accelerate the clotting process and explore the wound area. It is also used for holding and fixing the superficial fascia during undermining the wounds. A haemostat stops the bleeding condition by absorbing the coagulation issues, tissue bonding and carrying procoagulant factors to the victim’s haemorrhage site.

The key industry growth drivers for haemostats market are the growing ageing population, increasing cardiovascular surgical procedures, evolving personal healthcare expenditure and accelerating economic growth. The market is trending with rising pharmaceuticals research and development (R&D) expenditures and escalating e-commerce pharmaceutical products sales. However, there are some growth hindering factors in the market include stringent regulations and intense competition.

Regionally, the U.S. is expected to hold the leading position in the market, due to surging demand for thrombin and fibrin sealants by the physicians for adhering the patients damaged tissues & sealing the injured blood vessel(s) during operation.

“Global Haemostats Market: Industry Analysis & Outlook (2019-2023)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. Key players i.e. Johnson & Johnson (Ethicon Inc.), Pfizer Inc., Baxter International Inc. and Becton, Dickinson and Company are being profiled along with their respective financials and growth strategies.


1. Market Overview
1.1 Introduction
Table 1: Types of Haemostats
1.2 Classification
1.3 Product Mechanism
2. Global Haemostats Market
2.1 Global Haemostats Market Value Forecast
Table 2: Global Haemostats Market Value Forecast (2018-2023)
2.2 Global Haemostats Market Value by Products
Table 3: Global Haemostats Market Value by Products (2018)
2.2.1 Global Flowables Haemostats Market Value Forecast
Table 4: Global Flowables Haemostats Market Value Forecast (2018-2023)
2.2.2 Global Thrombin Haemostats Market Value Forecast
Table 5: Global Thrombin Haemostats Market Value Forecast (2018-2023)
2.2.3 Global Fibrin Sealants Haemostats Market Value Forecast
Table 6: Global Fibrin Sealants Haemostats Market Value Forecast (2018-2023)
2.3 Global Haemostats Market Value by Surgery Type
Table 7: Global Haemostats Market Value by Surgery Type (2018)
2.4 Global Haemostats Market Value by Region
Table 8: Global Haemostats Market Value by Region (2018)
3. Regional Haemostats Market
3.1 The U.S. Haemostats Market Value Forecast
Table 9: The U.S. Haemostats Market Value Forecast (2018-2023)
3.2 The U.S. Haemostats Market Value by Products
Table 10: The U.S. Haemostats Market Value by Products (2018)
3.2.1 The U.S. Flowables Haemostats Market Value Forecast
Table 11: The U.S. Flowables Haemostats Market Value Forecast (2018-2023)
3.2.2 The U.S. Thrombin Haemostats Market Value Forecast
Table 12: The U.S. Thrombin Haemostats Market Value Forecast (2018-2023)
3.2.3 The U.S. Fibrin Sealants Haemostats Market Value Forecast
Table 13: The U.S. Fibrin Sealants Haemostats Market Value Forecast (2018-2023)
3.3 Europe Haemostats Market Value Forecast
Table 14: Europe Haemostats Market Value Forecast (2018-2023)
3.4 Europe Haemostats Market Value by Products
Table 15: Europe Haemostats Market Value by Products (2018)
3.4.1 Europe Fibrin Sealants Haemostats Market Value Forecast
Table 16: Europe Fibrin Sealants Haemostats Market Value Forecast (2018-2023)
3.4.2 Europe Flowables Haemostats Market Value Forecast
Table 17: Europe Flowables Haemostats Market Value Forecast (2018-2023)
3.5 Europe Haemostats Market Value by Country
Table 18: Europe Haemostats Market Value by Country (2018)
3.5.1 Germany Haemostats Market Value Forecast
Table 19: Germany Haemostats Market Value Forecast (2018-2023)
3.5.2 Italy Haemostats Market Value Forecast
Table 20: Italy Haemostats Market Value Forecast (2018-2023)
3.5.3 Spain Haemostats Market Value Forecast
Table 21: Spain Haemostats Market Value Forecast (2018-2023)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Ageing Population
Table 22: Global Ageing Population (2014-2018)
4.1.2 Increasing Cardiovascular Surgical Procedures
Table 23: North America Cardiovascular Surgical Procedures (2014-2018)
4.1.3 Evolving Personal HealthCare Expenditure
Table 24: Global HealthCare Expenditure Per Capita (2014-2018)
4.1.4 Accelerating Economic Growth
Table 25: Global Gross Domestic Product (GDP) per Capita (2014-2018)
4.2 Key Trends and Developments
4.2.1 Rising Pharmaceuticals Research and Development (R&D) Expenditures
Table 26: Global Pharmaceuticals Research and Development (R&D) Expenditures (2014-2018)
4.2.2 Escalating E-Commerce Pharmaceutical Products Sales
Table 27: Global E-Commerce Pharmaceutical Products Market Value Forecast (2018-2023)
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 Intense Competition
5. Competitive Landscape
5.1 Global Haemostats Market
5.1.1 Key Players - Revenue Comparison
Table 28: Key Players - Revenue Comparison (2018)
5.1.2 Key Players – Market Cap Comparison
Table 29: Key Players – Market Cap Comparison (2019)
5.1.3 Key Players – Product Feature Comparison
Table 30: Key Players – Product Feature Comparison (2018)
5.1.4 Key Players – Product Price Comparison
Table 31: Key Players – Product Price Comparison (2018)
5.2 US Haemostats Market
5.2.1 Key Players – Market Share Comparison
Table 32: Key Players – US Market Share Comparison (2018)
5.2.2 Key Players – Product Market Share Comparison
Table 33: Key Players – US Product Market Share Comparison (2018)
5.3 Europe Haemostats Market
5.3.1 Key Players – Product Market Share Comparison
Table 34: Key Players – Europe Product Market Share Comparison (2018)
5.4 Germany Haemostats Market
5.4.1 Key Players - Product Market Share Comparison
Table 35: Key Players – Germany Product Market Share Comparison (2018)
5.5 France Haemostats Market
5.5.1 Key Players - Product Market Share Comparison
Table 36: Key Players – France Product Market Share Comparison (2018)
6. Company Profiles
6.1 Johnson & Johnson (Ethicon Inc.)
6.1.1 Business Overview
Table 37: J&J (Ethicon) Sales by Business Segments (2018)
6.1.2 Financial Overview
Table 38: J&J (Ethicon) Sales and Net Earnings (2014-2018)
6.1.3 Business Strategies
Table 39: J&J (Ethicon) R&D Expenditures (2016-2018)
Table 40: J&J (Ethicon) Significant Agreements (2019)
6.2 Pfizer Inc.
6.2.1 Business Overview
Table 41: Pfizer Revenues by Business Segments (2018)
6.2.2 Financial Overview
Table 42: Pfizer Revenues and Net Income (2014-2018)
6.2.3 Business Strategies
Table 43: Pfizer R&D Expenditures (2016-2018)
6.3 Baxter International Inc.
6.3.1 Business Overview
Table 44: Baxter International Net Sales by Business Regions (2018)
6.3.2 Financial Overview
Table 45: Baxter International Net Sales and Net Income (2014-2018)
6.3.3 Business Strategies
Table 46: Baxter International R&D Expenditures (2016-2018)
6.4 Becton, Dickinson and Company
6.4.1 Business Overview
Table 47: Becton and Dickinson Revenues by Business Segment (2018)
6.4.2 Financial Overview
Table 48: Becton and Dickinson Revenues and Net Income (2014-2018)
6.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook